Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Colorectal Neoplasms

Free Subscription 13.10.2025 1 Ann Oncol 3 Ann Surg Oncol 5 BMC Cancer 6 BMC Gastroenterol 1 Br J Cancer 4 Cancer 1 Cancer Lett 1 Cancer Res 2 Clin Res Hepatol Gastroenterol 1 Eur J Cancer 1 Gut 2 Hum Pathol 4 Int J Cancer 4 Int J Colorectal Dis 1 J Am Coll Surg 3 J Natl Cancer Inst 1 J Surg Oncol 1 Oncogene 5 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Oncol

1. SELIGMANN JF, Morton D, Elliott F, Handley K, et al
   Corrigendum to "Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population": [Ann Oncol 36 (2025) 520-528].
   Ann Oncol. 2025 Oct 9:S0923-7534(25)04703-9. doi: 10.1016/j.annonc.2025.
   PubMed        
   
   

   
   Ann Surg Oncol

2. ERKAYA M, Benlice C, Karahan S, Oruc M, et al
   Adjuvant Chemotherapy and Survival in MSI-High Stages II and III Colon Cancer: Impact of Histopathologic Risk Stratification.
   Ann Surg Oncol. 2025 Oct 7. doi: 10.1245/s10434-025-18285.
   PubMed         Abstract available
   
   
3. ERKAYA M, Benlice C, Karahan S, Oruc M, et al
   ASO Visual Abstract: Adjuvant Chemotherapy and Survival in MSI-High Stage II and III Colon Cancer: Impact of Histopathological Risk Stratification.
   Ann Surg Oncol. 2025 Oct 10. doi: 10.1245/s10434-025-18485.
   PubMed        
   
   
4. MARINCOLA SMITH P, White MG
   ASO Author Reflections: Role of Repeat Cytoreductive Surgery for Patients with Recurrent Colorectal-Cancer-Related Peritoneal Metastases.
   Ann Surg Oncol. 2025 Oct 8. doi: 10.1245/s10434-025-18522.
   PubMed        
   
   

   
   BMC Cancer

5. YOU JH, Deng YB, Li YB, Zhang Y, et al
   The surgical effect of inferior mesenteric artery ligation level in rectal cancer and sigmoid colon cancer: a meta-analysis of randomized controlled trials.
   BMC Cancer. 2025;25:1531.
   PubMed         Abstract available
   
   
6. ZHOU Q, Zhou C, Zhang G, Xia X, et al
   Age-related differences in adjuvant chemotherapy use and outcomes in stage II colon cancer: a retrospective cohort study.
   BMC Cancer. 2025;25:1527.
   PubMed         Abstract available
   
   
7. YE J, Sun B, Xia F, Wang G, et al
   Berberine: a promising strategy to combat cetuximab-resistance in colorectal cancer.
   BMC Cancer. 2025;25:1520.
   PubMed         Abstract available
   
   
8. HAN C, Burd C, Plascak J, Tounkara F, et al
   AI-driven chemotoxicity prediction in colorectal cancer: impact of race, SDOH, and biological aging.
   BMC Cancer. 2025;25:1513.
   PubMed         Abstract available
   
   
9. GHOLIZADE M, Yazdani E, Hosseini-Baharanchi FS, Nikoofar A, et al
   Variations in radiomic features of the femoral head and neck during helical tomotherapy in prostate and rectal cancer patients.
   BMC Cancer. 2025;25:1509.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

10. DONG M, Ding Z, Liang X, Gao M, et al
    A Notch signal pathway related gene signature predicts overall survival in colorectal cancer.
    BMC Gastroenterol. 2025;25:704.
    PubMed         Abstract available
    
    
11. SOHEILIPOUR M, Noursina A, Nekookhoo M, Malekpour E, et al
    The pathobiont role of Akkermansia muciniphila in colorectal cancer: a systematic review.
    BMC Gastroenterol. 2025;25:702.
    PubMed         Abstract available
    
    
12. SOFF J, Benz SR, Kowalski C, Hansinger J, et al
    Heterogeneity of treatment preferences in the absence of guideline recommendations - a case vignette study in colorectal cancer tumor boards in Germany, Austria and Switzerland.
    BMC Gastroenterol. 2025;25:700.
    PubMed         Abstract available
    
    
13. WANG C, Fu P, Sheng J
    MMP11 predicts colorectal cancer outcomes and its inhibitor RXP03 exerts anti-tumor effects via apoptosis activation.
    BMC Gastroenterol. 2025;25:699.
    PubMed         Abstract available
    
    
14. LAN Y, Zhang L, Li R
    The diagnostic value of serum cysteine protease inhibitor (CST4) in colorectal cancer: a preliminary study.
    BMC Gastroenterol. 2025;25:692.
    PubMed         Abstract available
    
    
15. CHEN L, Wang D, Meng C, Sun H, et al
    Glutamine prevents diarrhea in colorectal cancer patients undergoing chemotherapy or chemoradiotherapy: a meta-analysis.
    BMC Gastroenterol. 2025;25:697.
    PubMed         Abstract available
    
    

    
    Br J Cancer

16. OSTERMAN E, Syriopoulou E, Martling A, Andersson TM, et al
    Impact of socioeconomics on recurrences and survival in non-metastasized colorectal cancer.
    Br J Cancer. 2025 Oct 4. doi: 10.1038/s41416-025-03224.
    PubMed         Abstract available
    
    

    
    Cancer

17. KO B, Rojanasopondist P, Grady WM
    Top advances of the year: Noninvasive colorectal cancer screening tests.
    Cancer. 2025;131:e70115.
    PubMed         Abstract available
    
    
18. BUCHLER T, Ambrozova M, Majek O, Dianova T, et al
    Risk of second primary malignancies after adjuvant chemotherapy for colon cancer.
    Cancer. 2025;131:e70116.
    PubMed         Abstract available
    
    
19. CORONADO GD, Gautom P, Schneider JL, Edelmann AC, et al
    Multilevel challenges and adaptations to patient navigation programs for colorectal cancer screening and follow-up: Findings from the Accelerating Colorectal Cancer Screening and follow-up through Implementation Science consortium.
    Cancer. 2025;131:e70121.
    PubMed         Abstract available
    
    
20. FOLKERTS AD, Janczewski LM, Merkow RP
    Liver-directed therapies for colorectal liver metastases.
    Cancer. 2025;131:e70097.
    PubMed         Abstract available
    
    

    
    Cancer Lett

21. GUO Z, He L, Wang W, Tian S, et al
    Corrigendum to "FUT2-dependent fucosylation of LAMP1 promotes the apoptosis of colorectal cancer cells by regulating theautophagy-lysosomal pathway" [Cancer Lett. (2025) 619 217643].
    Cancer Lett. 2025 Oct 3:217981. doi: 10.1016/j.canlet.2025.217981.
    PubMed        
    
    

    
    Cancer Res

22. LIU S, Zhang Z, Wang Z, Liu C, et al
    SPP1 Drives Colorectal Cancer Liver Metastasis and Immunotherapy Resistance by Stimulating CXCL12 Production in Cancer-Associated Fibroblasts.
    Cancer Res. 2025 Oct 6. doi: 10.1158/0008-5472.CAN-24-4916.
    PubMed         Abstract available
    
    

    
    Clin Res Hepatol Gastroenterol

23. AZIMI A, Jolfayi AG, Rezayifar V, Ateen F, et al
    The association between metabolic-associated fatty liver diseases and risk of colorectal polyps, neoplasia, and cancer: A systematic review and meta-analysis of over 56 million individuals.
    Clin Res Hepatol Gastroenterol. 2025;49:102652.
    PubMed         Abstract available
    
    
24. VITELLIUS C, Morvant B, Pedrono E, Lambert D, et al
    Results of a French screening campaign comparing clinical and molecular characteristics of interval colorectal cancers to cancers detected using a guaiac test.
    Clin Res Hepatol Gastroenterol. 2025;49:102678.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

25. YAMAMOTO K, Bando H, Misumi T, Nishikawa T, et al
    Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: An ARCAD database study.
    Eur J Cancer. 2025;230:116034.
    PubMed         Abstract available
    
    

    
    Gut

26. STEUP C, Kennel K, Neurath MF, Fichtner-Feigl S, et al
    Current and emerging concepts for systemic treatment of metastatic colorectal cancer.
    Gut. 2025 Oct 5:gutjnl-2025-335412. doi: 10.1136/gutjnl-2025-335412.
    PubMed         Abstract available
    
    

    
    Hum Pathol

27. MANI P, Mehra L, Deepak R, Tiwari A, et al
    Evaluation of a novel surrogate panel for classifying human colorectal carcinomas according to consensus molecular subtypes.
    Hum Pathol. 2025;160:105840.
    PubMed         Abstract available
    
    
28. ZADA S, Aslam S, Shah S, Chandan VS, et al
    Reassessing the routine histopathological evaluation of anastomotic doughnuts in colorectal procedures: A 10-year retrospective study.
    Hum Pathol. 2025;160:105836.
    PubMed         Abstract available
    
    

    
    Int J Cancer

29. HEISSER T, Cardoso R, Niedermaier T, Hoffmeister M, et al
    Optimizing colonoscopy-based colorectal cancer screening by low-barrier, low-threshold pretesting.
    Int J Cancer. 2025 Oct 9. doi: 10.1002/ijc.70187.
    PubMed         Abstract available
    
    
30. VANACLOCHA-ESPI M, Romeo-Cervera P, Castan-Cameo S, Perez-Sanz E, et al
    Risk of advanced adenoma detection in colorectal cancer screening programmes according to personal characteristics and screening history.
    Int J Cancer. 2025 Oct 6. doi: 10.1002/ijc.70182.
    PubMed         Abstract available
    
    
31. KAUPPINEN AK, Olkinuora AP, Mecklin JP, Peltomaki PT, et al
    Molecular analysis of the evolutionary history of endometrial and ovarian carcinoma in Lynch syndrome.
    Int J Cancer. 2025 Aug 7. doi: 10.1002/ijc.70074.
    PubMed         Abstract available
    
    
32. ROZEMEIJER K, Dias Goncalves Lima F, Kuyvenhoven EJ, de Vries HJC, et al
    Swab-based anal cancer screening in men living with HIV: Projected outcomes for different screening algorithms.
    Int J Cancer. 2025 Aug 5. doi: 10.1002/ijc.70046.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

33. ITO R, Matsuda T, Hasegawa H, Otowa Y, et al
    Phase-specific learning curves in robot-assisted rectal surgery: implications for surgical training.
    Int J Colorectal Dis. 2025;40:213.
    PubMed         Abstract available
    
    
34. LIN CC, Chang CY, Lin YZ, Cheng HH, et al
    Early- vs. late-onset colon cancer: clinicopathological insights and survival outcomes in an East Asian cohort.
    Int J Colorectal Dis. 2025;40:212.
    PubMed         Abstract available
    
    
35. CHOI JDW, Huynh N, Shepherd T, Shanmugalingam A, et al
    The efficacy and safety of extended thromboprophylaxis after colorectal surgery: a systematic review and meta-analysis.
    Int J Colorectal Dis. 2025;40:211.
    PubMed         Abstract available
    
    
36. UEMURA M, Kusunoki C, Sekido Y, Takeda M, et al
    Saireito (TJ-114) for Preventing High-Output Syndrome After Temporary Ileostomy in Rectal Cancer Surgery.
    Int J Colorectal Dis. 2025;40:209.
    PubMed         Abstract available
    
    

    
    J Am Coll Surg

37. PIRI J, Ma R, La K, Barnajian M, et al
    Racial, Ethnic, and Sex Enrollment Disparity in Clinical Trials Leading to FDA Approval for Neoadjuvant Immunotherapy for Colorectal Cancer.
    J Am Coll Surg. 2025 Oct 6. doi: 10.1097/XCS.0000000000001549.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

38. IFHAM HANIF M, Sholihah MM
    RE: Effects of a high-fiber, high-fruit, and high-vegetable, low-fat dietary intervention on the rectal tissue microbiome.
    J Natl Cancer Inst. 2025;117:2142-2143.
    PubMed         Abstract available
    
    
39. MEESTER RGS, Piscitello AJ, Duimstra JA, Liang PS, et al
    Comparative benefits, burdens and harms of emerging blood-based tests for colorectal cancer screening.
    J Natl Cancer Inst. 2025 Oct 6:djaf277. doi: 10.1093.
    PubMed         Abstract available
    
    
40. BRAY F, Laversanne M
    Stat Bite: recent trends in colon cancer incidence at ages 25-49 vs 50-74 in 50 countries.
    J Natl Cancer Inst. 2025;117:2146-2147.
    PubMed        
    
    

    
    J Surg Oncol

41. BEPPU T, Masuda T, Miyata T, Imai K, et al
    The Growing Potential of Thermal Ablation for Colorectal Liver Metastases.
    J Surg Oncol. 2025;132:895-907.
    PubMed         Abstract available
    
    

    
    Oncogene

42. HUANG M, Qin B, Xie Z, Zhou R, et al
    Publisher Correction: RCN3 functions as a tumor promoter in colorectal cancer by modulating the GRP78-PI3K-AKT signaling pathway.
    Oncogene. 2025 Oct 8. doi: 10.1038/s41388-025-03592.
    PubMed        
    
    

    
    PLoS One

43. BARDAWEEL SK, Abu Sneineh B, Hajjo R, Abu Khalaf R, et al
    DPP4 inhibitors as a novel therapeutic strategy in colorectal cancer: Integrating network biology and experimental insights.
    PLoS One. 2025;20:e0334223.
    PubMed         Abstract available
    
    
44. ABU ALSAMEN DR, Zakaraya ZZ, Abed A, Alsa'd AA, et al
    Synergistic anticancer effects of ABT-199 and Vorinostat encapsulated in PLGA nanoparticles: Formulation, characterization, and antiproliferative effects against colorectal cancer cells.
    PLoS One. 2025;20:e0334427.
    PubMed         Abstract available
    
    
45. MALAGON M, Ramio-Pujol S, Serrano M, Amoedo J, et al
    Correction: New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population.
    PLoS One. 2025;20:e0334314.
    PubMed         Abstract available
    
    
46. CAO Y, Yang L, Fan L, Liu X, et al
    Trends in incidence, mortality and disability-adjusted life years of colorectal cancer in East Asia (1990-2021): An analysis of the Global Burden of Disease study 2021.
    PLoS One. 2025;20:e0334229.
    PubMed         Abstract available
    
    
47. MORSHNEVA A, Gnedina O, Igotti M
    An in vitro tumor recurrence model based on platinum-resistant colon cancer cells as a research tool for studying cancer cell dormancy.
    PLoS One. 2025;20:e0333671.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.